Table 2

MYC and MYCN amplification statuses and outcomes parameters in relation to the histologic subtypes.

Histological subtypesTotal
ClassicWith extensive nodularityAnaplastic/large-cellDesmoplastic/nodularn (%)
MYC amplification
Positive0ND**202 (10.5)
Negative9ND**2617 (89.5)
MYCN amplification
Positive1ND**001 (5.3)
Negative8ND**4618 (94.7)
*Metastasis50117 (17.9)
*Recurrence42208 (14)
*Mortality20215 (8.8)
  • * Follow up period is 5 years from the date of diagnosis

  • ** ND - Not done